July 2022 "Today we are celebrating ten years of Exscientia ! Founded as a spinout from the University of Dundee on 20 July 2012, Exscientia pioneered the design We’re excited about delivering the next ten years of Exscientia and advancing AI to design better drugs

., of the University of Oxford , has joined Exscientia as Chief Scientist of Biologics AI. Professor Deane joins Exscientia’s technology leadership team, reporting to Chief Technology Officer, She will maintain both of these roles, in addition to her role at Exscientia .

January 2022 Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Collaborative efforts aim to accelerate drug discovery and improve clinical success Agreement to utilize Exscientia Research will be focused on up to 15 novel small molecule candidates across oncology and immunology Exscientia $5.2 billion in total milestones plus tiered royalties PARIS & OXFORD, England & BOSTON-- Sanofi and Exscientia The companies have been working together since 2016 and in 2019, Sanofi in-licensed Exscientia ’s novel

Fiona Marshall in the news Addex Therapeutics Q1 2021 financial results Exscientia Receives Queen’s Award for Enterprise in Innovation SoftBank leads funding that could net up to $525M for Exscientia's AI drug